NCT00682773View on ClinicalTrials.gov

Enhancing the Safety of Warfarin in Nursing Homes

NACompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

December 31, 2008

Study Completion Date

September 30, 2009

Conditions
Adverse Drug Events (ADEs)
Interventions
OTHER

SBAR

Educational intervention for nursing staff on effective communication regarding warfarin treatment/care; use of SBAR communication forms.

Trial Locations (2)

06457

Qualidigm, Middletown

01605

Meyers Primary Care Institute, Worcester

All Listed Sponsors
collaborator

Agency for Healthcare Research and Quality (AHRQ)

FED

collaborator

Qualidigm

INDUSTRY

lead

University of Massachusetts, Worcester

OTHER

NCT00682773 - Enhancing the Safety of Warfarin in Nursing Homes | Biotech Hunter | Biotech Hunter